Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 05/01/20
Due: 05/01/21
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 04/30/19
Due: 04/30/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer | NCT03300765 | Xiayun He, MD | user2@example.com | None | 2017-07-01 | 2020-05-01 | 2021-05-01 | - | - | 2025-07-14 |
| Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | NCT03389295 | Xiayun He, MD | user2@example.com | None | 2010-01-31 | 2019-04-30 | 2020-04-30 | - | - | 2025-07-14 |